Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lowe's Companies
LOW
|
+$217M |
| 2 |
JPMorgan Chase
JPM
|
+$213M |
| 3 |
Intel
INTC
|
+$200M |
| 4 |
FISV
Fiserv Inc
FISV
|
+$184M |
| 5 |
TECD
Tech Data Corp
TECD
|
+$174M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$685M |
| 2 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$127M |
| 3 |
Meta Platforms (Facebook)
META
|
+$122M |
| 4 |
Merck
MRK
|
+$110M |
| 5 |
NVIDIA
NVDA
|
+$108M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 46.75% |
| 2 | Healthcare | 9.01% |
| 3 | Technology | 7.75% |
| 4 | Financials | 7.01% |
| 5 | Consumer Discretionary | 6.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2101
Omega Healthcare
OHI
$14B
| $3.27M | ﹤0.01% |
109,808
+47,556
| +76% | +$1.41M |
|
|
ORAN
2102
DELISTED
Orange
ORAN
| $3.27M | ﹤0.01% |
274,344
+27,512
| +11% | +$328K |
|
2103
Cohu
COHU
$2.45B
| $3.26M | ﹤0.01% |
188,150
+88,514
| +89% | +$1.36M |
|
2104
New York Times
NYT
$11B
| $3.26M | ﹤0.01% |
77,472
-232,326
| -75% | -$8.45M |
|
2105
Vishay Intertechnology
VSH
$4.87B
| $3.25M | ﹤0.01% |
212,970
+81,546
| +62% | +$1.27M |
|
2106
ProShares VIX Short-Term Futures ETF
VIXY
$212M
| $3.25M | ﹤0.01% |
+1,464
| New | +$3.61M |
|
|
VSTO
2107
DELISTED
Vista Outdoor Inc.
VSTO
| $3.25M | ﹤0.01% |
224,775
+187,374
| +501% | +$1.88M |
|
2108
Corvus Pharmaceuticals
CRVS
$1.24B
| $3.24M | ﹤0.01% |
1,192,742
+160,983
| +16% | +$476K |
|
2109
AerCap
AER
$23.3B
| $3.23M | ﹤0.01% |
104,997
-451
| -0.4% | -$12.9K |
|
|
AKRO
2110
DELISTED
Akero Therapeutics
AKRO
| $3.23M | ﹤0.01% |
129,565
+65,026
| +101% | +$1.49M |
|
|
VAR
2111
DELISTED
Varian Medical Systems, Inc.
VAR
| $3.22M | ﹤0.01% |
26,254
-34,738
| -57% | -$4.02M |
|
|
PCH
2112
DELISTED
PotlatchDeltic
PCH
| $3.21M | ﹤0.01% |
+84,374
| New | +$2.85M |
|
2113
Urban Edge Properties
UE
$2.69B
| $3.21M | ﹤0.01% |
270,109
-499,401
| -65% | -$5.01M |
|
2114
Ironwood Pharmaceuticals
IRWD
$701M
| $3.2M | ﹤0.01% |
310,298
+286,318
| +1,194% | +$2.93M |
|
2115
ING
ING
$100B
| $3.2M | ﹤0.01% |
463,434
+331,873
| +252% | +$2.01M |
|
|
CLDT
2116
Chatham Lodging
CLDT
$622M
| $3.2M | ﹤0.01% |
+522,284
| New | +$3.5M |
|
|
DBD
2117
DELISTED
Diebold Nixdorf Incorporated
DBD
| $3.2M | ﹤0.01% |
527,362
+514,159
| +3,894% | +$2.54M |
|
2118
TIM SA
TIMB
$8.44B
| $3.19M | ﹤0.01% |
246,772
-124,306
| -33% | -$1.55M |
|
|
REVG
2119
DELISTED
REV Group
REVG
| $3.19M | ﹤0.01% |
523,310
+408,169
| +354% | +$2.19M |
|
2120
Clearwater Paper
CLW
$340M
| $3.18M | ﹤0.01% |
+88,027
| New | +$2.45M |
|
2121
Horizon Bancorp
HBNC
$1B
| $3.18M | ﹤0.01% |
297,423
+73,917
| +33% | +$754K |
|
|
CADE
2122
DELISTED
Cadence Bank
CADE
| $3.17M | ﹤0.01% |
139,576
-49,509
| -26% | -$1.05M |
|
|
BMTX
2123
DELISTED
BM Technologies, Inc.
BMTX
| $3.17M | ﹤0.01% |
290,000
-835,000
| -74% | -$8.8M |
|
2124
Trimble
TRMB
$14.3B
| $3.17M | ﹤0.01% |
73,449
-41,488
| -36% | -$1.56M |
|
2125
Steven Madden
SHOO
$3.27B
| $3.17M | ﹤0.01% |
128,273
-54,585
| -30% | -$1.28M |
|
Similar funds
Israel Englander's Q2 2020 Portfolio in Review
As of Q2 2020, Israel Englander held 4,914 positions worth $73B, up 64% from $44.5B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Israel Englander deployed $10.9B of net new capital in Q2 2020, opening 1,140 new positions and adding to 1,565 existing holdings. Its largest new stake was Global Payments: 1,008,446 shares worth $171M.
By sector, the portfolio is most concentrated in Miscellaneous at 47% of assets, down from 48% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was iShares 1-5 Year Investment Grade Corporate Bond ETF, an estimated $127M trimmed.
- Israel Englander's largest Q2 2020 buy was Global Payments: 1,008,446 shares worth $171M.
- Israel Englander added most to Lowe's Companies in Q2 2020, an estimated $217M increase.
- Israel Englander's biggest Q2 2020 reduction was iShares 1-5 Year Investment Grade Corporate Bond ETF, cutting an estimated $127M.
- Israel Englander fully exited Allergan plc in Q2 2020, selling an estimated $685M.
- Israel Englander's ten largest holdings make up 20% of its $73B portfolio in Q2 2020.
- Israel Englander opened 1,140 new positions and closed 798 in Q2 2020.
- Israel Englander's portfolio value rose 64% quarter-over-quarter to $73B.
Based on Millennium Management's 13F filing for Q2 2020, filed 14 Aug 2020.